KNSY Related FDA

May 26, 2010 11:00 AM Kensey Nash (KNSY) Receives 501(k) Clearance from U.S. FDA for Meso BioMatrix Product

Nov 11, 2009 12:16 PM Kensey Nash (KNSY) Receives FDA Clearance for its First Extracellular Matrix Product, Medeor

Jun 23, 2009 07:05 AM Spectranetics (SPNC) Announces CE Mark Approval for ThromCatXT

Oct 23, 2006 07:53 AM Kensey Nash's (KNSY) ThromCat Thrombectomy Catheter System Receives CE Mark Approval

Sep 27, 2006 12:10 PM Kensey Nash (KNSY) Receives FDA Clearance for OrthoFill Bone Void Filler

Jul 12, 2006 02:36 PM Kensey Nash (KNSY) Announced FDA 510(k) Clearance for TriActiv FX

Apr 27, 2006 10:42 AM Kensey Nash (KNSY) Received 510(k) Clearance From FDA For ThromCat

Mar 10, 2006 01:02 PM KNSY Receives FDA 510 Clearance for QuickCat Extraction Catheter

Feb 15, 2006 10:36 AM KNSY Receives CE Mark Approval for New TriActiv ProGuard

Jan 23, 2006 07:18 AM KNSY Submits TriActiv FX Embolic Protection System 510(k)

Nov 7, 2005 03:46 PM KNSY Completed Enrollment in the ASPIRE Study

Mar 24, 2005 11:44 AM KNSY FDA Clearance for Its TriActiv Embolic Protection System

Mar 16, 2005 04:47 PM KNSY Comments on FDA Clearance; Guides Lower; Raises Buyback

Mar 7, 2005 06:21 AM KNSY Gets CE Mark for triActiv FX System